Abstract: P967 INFLUENCE OF METABOLIC SYNDROME (MS) FACTORS AND INSULIN RESISTANCE (IR) ON EZETIMIBE (E)/SIMVASTATIN (S) AND ATORVASTATIN (A) EFFICACY IN PATIENTS WITH MS AND MODERATELY HIGH (MH) OR HIGH (H) CHD RISK

Autor: Rosen, J, Ballantyne, C, Grundy, S, Hsueh, W, Parving, H, Robinson, J, Lin, J, Lowe, R, Shah, A, Tershakovec, A
Zdroj: In Atherosclerosis (Supplements) (Component) 2009 10(2):e1120-e1121
Databáze: ScienceDirect
Externí odkaz: